In aged mice, the redox-regulated transcription factor nuclear factor-B (NF-B) becomes constitutively active in many tissues, as well as in cells of the hematopoietic system. This oxidative stress-induced activity promotes the production of a number of pro-inflammatory cytokines, which can contribute to the pathology of many disease states associated with aging. The administration to aged mice of agents capable of activating the ␣ isoform of the peroxisome proliferator-activated receptor (PPAR␣) was found to restore the cellular redox balance, evidenced by a lowering of tissue lipid peroxidation, an elimination of constitutively active NF-B, and a loss in spontaneous inflammatory cytokine production. Aged animals bearing a null mutation in PPAR␣ failed to elicit these changes following treatment with PPAR␣ activators, but remained responsive to vitamin E supplementation. Aged C57BL/6 mice were found to express reduced transcript levels of PPAR␣ and the peroxisomeassociated genes acyl-CoA oxidase and catalase. Supplementation of these aged mice with PPAR␣ activators or with vitamin E caused elevations in these transcripts to levels seen in young animals. Our results suggest that PPAR␣ and the genes under its control play a role in the evolution of oxidative stress excesses observed in aging.
Multicellular organisms have evolved complex homeostatic mechanisms to sense and respond to a diverse range of exogenous and endogenous signals. One such mechanism appears to require the biochemical events which follow the activation of a peroxisome proliferator-activated receptor (PPAR). 1 PPARs are members of the nuclear steroid hormone receptor superfamily and function to transduce a variety of environmental, nutritional, and inflammatory signals into a defined set of cellular responses (1) . Three PPAR isoforms, ␣, ␤/␦, and ␥, have been identified (1) (2) (3) . Each exhibits a high degree of sequence and structural homology (2), but they possess individual patterns of tissue distribution (4, 5) . Activation of a PPAR causes the receptor to heterodimerize with a 9-cis-retinoic acid receptor (6) , thereby conferring upon it the ability to bind DNA and transcriptionally regulate a subset of genes possessing a peroxisome proliferator response element, consensus 5Ј-AACTAG-GTCAAAGGTCA-3Ј (7), in their promoter region (1, 8, 9) .
While PPARs had long been considered to be orphan receptors, recent reports indicate that a number of natural and xenobiotic ligands with specificity for PPARs do indeed exist. The first ligands described were the insulin-sensitizing thiazoladinediones which are specific ligands for the PPAR␥ isoform (10) . Since that time, a number of natural endogenous molecules have been found to be capable of activating PPARs. For example, 15-deoxy-⌬ 12,14 prostaglandin J 2 represents a natural PPAR␥ ligand (11, 12) . Many specific fatty acid species and their derivatives, especially polyunsaturated fatty acids (13) (14) (15) (16) , the inflammatory mediator leukotriene B 4 (17) , and the eicosanoid 8(S)-hydroxyeicosatetraenoic acid (18) , have now been demonstrated to be ligands for PPAR␣. Studies employing the PPAR␣-deficient mouse have also revealed that the natural steroid hormone dehydroepiandrosterone-3␤-sulfate (DHEAS) is a specific activator of PPAR␣ (19) . Furthermore, a vast array of man-made compounds are capable of activating PPAR␣. These include the synthetic arachidonic acid analog eicosatetrayeinoic acid, the hypolipidemic agents WY-14,643 and clofibrate, certain non-steroidal anti-inflammatory drugs, phthalate ester plasticizers, plus a number of other xenobiotic compounds (1, 20, 21) . Based upon their capacity to elicit cellular responses to a variety of stimuli, the PPARs may represent a class of molecules which allow the biochemical adaptation to a diverse range of internal and external signals. These include nutritional and inflammatory agents as well as a number of potentially toxic substances. PPAR␣ activation results in the transcriptional up-regulation of many genes, including those involved in peroxisomal and mitochondrial fatty acid ␤-oxidation, some lipid binding proteins and apolipoproteins, certain isozymes of the cytochrome P450 family, and antioxidant enzymes (1, 17, 22, 23) . In addition, activation of PPARs has been demonstrated to antagonize signaling through an array of important pathways, including STATs, AP-1, and NF-B (13, 24 -28) .
There is strong evidence to suggest that the deleterious changes to the immune system that occur as an individual or experimental animal ages, including a reduced capacity to be effectively vaccinated and the dysregulated production of a number of pleiotropic cytokines, are associated with a decreased ability to effectively handle oxidative stress (29 -33) . That elevated levels of cellular oxidative stress are present in aged experimental animals is indicated by elevations in tissue and circulating lipid peroxide levels (32) (33) (34) as well as oxidized proteins (35, 36) . The redox-regulated and oxidant stress-activated transcription factor NF-B has been reported to be active in the heart, liver, kidney, brain, and cardiac muscle of aged experimental animals, without alterations in the amounts of NF-B subunits or of the inhibitory molecule IB␣ present in the cytosol (37) (38) (39) . Under resting conditions, NF-B exists in the cytoplasm as a dimer bound to the inhibitory protein IB. Signaling by various cell stimuli appear to converge at the generation of increased levels of intracellular reactive oxygen species (ROS), causing the phosphorylation and ubiquitination of IB and its release from NF-B. The NF-B dimer then translocates to the nucleus and binds to the promoter region of genes possessing a B motif (consensus GGGRNNT(Y)CC), thereby causing recruitment of transcriptional machinery and induction of gene transcription (40) .
We have recently demonstrated that NF-B is also present in an active state in the macrophages and lymphocytes which reside in the spleens of aged mice (34) . This active NF-B was demonstrated to correlate with the expression of the NF-Bregulated genes IL-6, IL-12, macrophage migration inhibitory factor, cyclooxygenase-2, and tumor necrosis factor-␣ (34). We found that the administration of specific PPAR␣ activators or the dietary antioxidant vitamin E to aged rodents effectively reduced the elevated levels of active NF-B, reestablished control over proinflammatory cytokine production, and reduced lipid peroxide levels in various tissues (34) . These findings suggest a role for PPAR␣ in the maintenance of redox balance during the aging process.
The studies presented herein demonstrate that low dose DHEAS or WY-14,643 administration to aged animals elicits a number of biologic changes, which are mediated through a process involving PPAR␣ activation. We employed a strain of mice bearing a null mutation in PPAR␣ (PPAR␣ Ϫ/Ϫ) to experimentally demonstrate that normal PPAR␣ function is necessary to effectively maintain a balance in cellular redox state. PPAR␣ Ϫ/Ϫ mice were found to express indicators of oxidative stress much earlier in their lifespans than wild-type mice. Administration of PPAR␣-specific activators to wild-type and knockout animals was capable of reducing the age-associated elevations in NF-B activity and constitutive pro-inflammatory cytokine production in the PPAR␣ wild-type animals but not their PPAR␣-deficient counterparts. Vitamin E supplementation lowered the levels of active NF-B present in the spleens of both aged wildtype and aged knockout animals. Similar results were obtained using young PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice rendered redoximbalanced at an early age by feeding a vitamin E-deficient diet. In addition, a decline in cellular PPAR␣ expression was observed to occur with normal aging. This was accompanied by similarly reduced levels of acyl-CoA oxidase and catalase mRNA expression, enzymes that are transcriptionally up-regulated following administration of PPAR␣ activators. Either vitamin E supplementation or treatment of aged mice with PPAR␣ activators was able to cause elevations in splenic PPAR␣, acyl-CoA oxidase, and catalase mRNA to levels typically observed in the spleens of young animals. Our findings indicate that the therapeutic administration of PPAR␣ activators is able to regulate cellular oxidant/antioxidant balance through a mechanism that appears to require a functional PPAR␣.
EXPERIMENTAL PROCEDURES
Animals and Diets-Colonies of PPAR␣ wild type (PPAR␣ ϩ/ϩ) and homozygous knockout (PPAR␣ Ϫ/Ϫ) mice were expanded from breeding pairs obtained from Dr. F. J. Gonzalez (Metabolism Branch, National Institutes of Health, Bethesda, MD). The derivation and phenotypic characteristics of these animals have previously been reported (41) . Female mice were used for all of the experiments reported herein.
Six-week-old and 20 -24-month-old female C57BL/6 mice were purchased from the National Institute on Aging. All mice were housed in the University of Utah Animal Resource Center, which routinely monitors for the most prevalent murine pathogens, employs sentinel animals as a means for early detection of murine hepatitis virus, and guarantees strict compliance with regulations established by the Animal Welfare Act. Normal maintenance chow, vitamin E-deficient (tocopherol-stripped) chow, and vitamin E-containing control chow were purchased from Harlan Teklad (Madison, WI). Mice were anesthetized with halothane and sacrificed by cervical dislocation. Any mice with evidence of gross internal or external pathology at the time of sacrifice were excluded from the study.
Supplementation Therapy-DHEAS (5-androsten-3␤-ol-17-one 3-sulfate) (Sigma), dissolved directly in the drinking water at a concentration of 100 g/ml, was prepared fresh on a weekly basis and was available to the mice ad libitum, resulting in doses of approximately 300 -500 g/day. WY-14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid) (Chemsyn Science Laboratories, Lenexa, KS) was added directly to the chow resulting in 250 g/day doses. ␣-Tocopherol (Sigma) was applied to the chow in order to achieve a supplemental vitamin E dose of 4.6 mg/day. Peroxisome-proliferating doses of DHEA (5-androsten-3␤-ol-17-one) (Sigma) and WY-14,643 were provided in the chow at 0.5% w/w (25 mg/day) and 0.1% w/w (5 mg/day), respectively. Freshly prepared food was provided every 2-3 days and was continuously available to the mice during the 2-week supplementation period.
Preparation of Nuclear Extracts-Nuclear extracts were prepared from cell suspensions of whole spleens using a modified protocol of Dignam et al. (42) . Briefly, cells were washed twice in ice-cold phosphate-buffered saline containing 1 mM phenylmethylsulfonyl fluoride (PMSF) and resuspended in 1 ml of buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 10 g/ml aprotinin, 100 M leupeptin, 1 mM PMSF, 1 mM DTT, and 0.5% Nonidet P-40) for 10 min on ice, vortexing every 2 min. Nuclei were collected by centrifugation at 1000 ϫ g for 5 min at 4°C. The nuclear pellet was washed with 1 ml of buffer A without Nonidet P-40. 25 l of buffer B (10 mM HEPES, pH 7.9, 420 mM NaCl, 25% glycerol, 5 mM MgCl 2 , 0.1 mM EDTA, 0.1 mM EGTA, 10 g/ml aprotinin, 100 M leupeptin, 1 mM PMSF, and 1 mM DTT) was added to the pellet and, following sonication for 10 s, incubated for 30 min on ice. Nuclear debris was removed by centrifugation at 13,000 ϫ g for 10 min. The supernatant was collected, the protein content of the nuclear extract determined (43) , and an electrophoretic mobility shift assay (EMSA) was performed. While contamination of the nuclear extracts with small quantities of cytosolic proteins is possible, cytosolic NF-B will not bind DNA due to its association with the inhibitory molecule IB (44) .
EMSA-Equal amounts of nuclear extracts (2 g of protein) were incubated with 30,000 cpm of 32 P labeled NF-B specific probe (Promega). Reactions were performed in a 20-l total volume containing 2 g of nuclear extract, 4 l of 5ϫ gel shift binding buffer (20 mM Tris-HCl, pH 7.9, 5 mM MgCl 2 , 0.5 mM DTT, 0.5 mM EDTA, and 20% glycerol), 1.5 g of poly(dI-dC), and 1 l of probe. For supershift assays, 2 l of an appropriate anti-NF-B subunit antibody (Santa Cruz Biotechnology, Inc.) was added to each reaction. The reaction was incubated at room temperature for 15 min, loaded on a 4% native polyacrylamide gel, and run in 0.5ϫ TBE buffer. The gel was dried and subjected to autoradiography. NF-B-specific bands were confirmed by competition with a 50-fold excess of an unlabeled NF-B probe, which resulted in no shifted band, or by preparing the reaction with excess labeled nonspecific probe, which did not reduce the intensity of the NF-B band.
Cell Culture and ELISA-Cells obtained from the spleens of PPAR␣ ϩ/ϩ or PPAR␣ Ϫ/Ϫ animals were cultured under serum-free conditions. Briefly, mice were anesthetized with halothane and sacrificed by cervical dislocation. Single cell suspensions were prepared from the spleens of these animals. The collected splenocytes were washed three times in Dulbecco's phosphate-buffered saline and cultured at 10 7 cells/ml in freshly prepared serum-free medium consisting of RPMI 1640, 1% Nutridoma-SR (Boehringer Mannheim), 200 mM L-glutamine, antibiotics, and 5 ϫ 10 Ϫ5 M 2-mercaptoethanol. Cells were incubated for 24 h at 37°C in an atmosphere of 5% CO 2 in air. Cell culture supernatants were then collected for quantitative evaluation of immunoactive IL-6 or IL-12 (p40) by ELISA, as described previously (45) . Monoclonal rat anti-murine cytokine antibodies and murine recombinant IL-6 and IL-12 cytokine standards were purchased from PharMingen (San Diego, CA).
Reverse Transcriptase (RT)-PCR-mRNA was prepared by the method of Chomczynski (46) and RT-PCR was performed with adaptations for rapid cycling with the 1605 air thermocycler (Idaho Technol-ogy, Idaho Falls, ID), as described previously (45) . PCR conditions were: denaturation, 94°C for 1 s, annealing for 1 s, and elongation, 72°C for 8 s. 16 cycles were performed for ␤-actin and 30 cycles were performed for PPAR␣, acyl-CoA oxidase, and catalase. Gene-specific sequences were derived from GenBank submissions. Oligonucleotides and annealing temperatures (AT) used for these analyses are as follows: ␤-actin (AT ϭ 60°C): 5Ј-GGG TCA GAA GGA CTC CTA TG-3Ј and 5Ј-GTA ACA ATG CCA TGT TCA AT-3Ј. PPAR␣ (AT ϭ 55°C): 5Ј-GTG GCT GCT ATA ATT TGC TGT G-3Ј and 5Ј-GAA GGT GTC ATC TGG ATG GGT G-3Ј. Acyl-CoA oxidase (AT ϭ 55°C): 5Ј-CGA CCT TGT TCG GGC AAG TGA GGC GC-3Ј and 5Ј-GGA GCT CAG ACG TGT CCC AGG G-3Ј. Catalase (AT ϭ 55°C): 5Ј-ATG TCG GAC AGT CGG GAC C-3Ј and 5Ј-CAT GTC AGG ATC CTT CAG G-3Ј.
Following PCR, the samples were mixed with an equal volume of stop solution, heated to 95°C for 5 min, and electrophoresed on a 6% acrylamide gel. Bands were detected by autoradiographic exposure for 16 h at Ϫ70°C. Sizes of the bands were determined by comparing to the migration pattern of a 32 P-end-labeled MspI digest of pBR322 (New England Biolabs, Beverly, MA).
Lipid Peroxidation Assay-Immediately following sacrifice, mouse livers were perfused with cold 0.9% NaCl via the portal vein prior to removal. Livers were weighed, and 10% homogenates were prepared in 1.15% KCl using a Tissue Tearor homogenizer. Supernatants obtained by centrifugation at 3500 ϫ g of liver homogenates were either left on ice or subjected to an oxidative stress in vitro by incubating them for 1 h at 37°C in the presence of 10 M FeSO 4 , after which time EDTA was added to a final concentration of 10 mM. Lipid peroxides were assayed using a modified procedure of Buege and Aust (47) . Briefly, 250 l of 10% tissue homogenate or working standard (1,1,3,3-tetramethoxypropane; Sigma) was added to 500 l of TCA-TBA-HCl reagent (15% w/w trichloroacetic acid, 0.375% w/v thiobarbituric acid, 0.25 N hydrochloric acid). The resulting mixture was vortexed and heated at 95°C for 15 min. The mixture was then cooled on ice for 15 min, centrifuged at 3000 rpm for 10 min, and the absorbance of the supernatant at 535 nm was determined using a Molecular Devices multiwell plate spectrophotometer. The degree of lipid peroxidation was expressed as concentration of thiobarbituric acid-reactive substances (TBARS) participating in the reaction per gram of tissue.
RESULTS
PPAR␣ Ϫ/Ϫ Mice Exhibit an Obese Phenotype-While expanding the PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mouse colonies, it became apparent that the body weights of 14-week-old PPAR␣ Ϫ/Ϫ mice were greater than age-matched PPAR␣ ϩ/ϩ mice. As has been described previously (48, 49) , an observed 30% increase in body weight persisted throughout adulthood, and the overweight phenotype was more exaggerated in males. Gross pathologic examination revealed a markedly increased amount of intraabdominal adipose tissue in the PPAR␣ Ϫ/Ϫ mice (data not shown). The recent report that PPAR␣ Ϫ/Ϫ mice demonstrate reduced basal levels of mitochondrial fat-metabolizing enzymes may offer an explanation for these observations (23) . An inability to efficiently catabolize fatty acids would cause them to be redirected for storage in adipose tissue, thereby accounting for the obese phenotype of PPAR␣ Ϫ/Ϫ mice. The reported inability of PPAR␣ Ϫ/Ϫ mice to transcriptionally upregulate enzymes for fatty acid catabolism in response to administration of PPAR␣ activators may be why these mice exhibit lipid droplets in their livers following an overnight fast (48, 49) , suggesting that endogenous molecules (i.e. fatty acids) are not capable of activating PPAR␣, or of being enzymatically metabolized, in the PPAR␣ Ϫ/Ϫ mice.
PPAR␣ Ϫ/Ϫ Mice Exhibit an Aged Proinflammatory Phenotype at a Younger Chronological Age than PPAR␣ ϩ/ϩ MiceWhen splenocytes were obtained from 4-month-old PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice and analyzed by EMSA for NF-B activity, PPAR␣ ϩ/ϩ mice did not express nuclear NF-B activity in their spleens, while age-matched PPAR␣ Ϫ/Ϫ mice already exhibited high levels of nuclear NF-B activity (Fig. 1A) . In vitro activation of splenocytes from PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice with a low dose of LPS (10 ng/ml) was able to modestly increase nuclear NF-B activity in both groups (Fig.   1A ). The levels of NF-B activity seen in splenocytes from 4-month-old PPAR␣ ϩ/ϩ mice following activation with LPS, however, did not reach the levels seen in splenocytes from age-matched PPAR␣ Ϫ/Ϫ mice in the absence of exogenous activators (Fig. 1A) . The secretion of two NF-B-driven cytokines, IL-6 and IL-12, by either control or LPS-activated splenocytes from PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice was quantitated by ELISA. PPAR␣ Ϫ/Ϫ splenocytes were found to produce 2-3 times more IL-6 and IL-12, both in the absence of exogenous stimulation (Fig. 1B) and following activation with LPS (Fig. 1C) , than splenocytes from PPAR␣ ϩ/ϩ mice.
Peroxisome Proliferating Doses, but Not Therapeutic Doses, of DHEAS or WY-14,643 Cause the Activation of NF-B in
Young PPAR␣ ϩ/ϩ Mice-We questioned whether the effects that we have previously reported to occur following the administration to aged mice of natural and xenobiotic agents capable of activating PPAR␣ (45, 50) 2 were dependent upon the presence of a functional PPAR␣. PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice FIG. 1. PPAR␣ ؊/؊ mice acquire a physiologically aged phenotype, indicative of a state of redox imbalance, at a younger age than PPAR␣ ؉/؉ mice. Splenocytes obtained from 4-month-old PPAR␣ ϩ/ϩ (open bars) or PPAR␣ Ϫ/Ϫ (filled bars) mice were cultured at equivalent cell densities in the absence or presence of 10 ng/ml LPS. After 45 min, cells were harvested, nuclear extracts were prepared, and an NF-B EMSA was performed (A). Data shown are typical of mice from each group. Cells treated with 0 ng/ml (B) or 10 ng/ml (C) LPS were cultured for 24 h, and IL-6 and IL-12 levels (mean Ϯ S.D. of 3 mice/group) in supernatants were quantitated by ELISA. at 2 and 15 months of age were compared in these studies. As has been previously demonstrated with C57BL/6 strain mice (45) , both PPAR␣ ϩ/ϩ, and PPAR␣ Ϫ/Ϫ mice at 2 months of age exhibited only minimal levels of nuclear NF-B activity in their spleens (Fig. 2) . When peroxisome-proliferating doses of DHEAS or WY-14,643 were added to the diets of young PPAR␣ ϩ/ϩ mice for a period of 2 weeks, a marked elevation in nuclear NF-B activity was consistently observed in spleen (Fig. 2 ) and liver tissue (data not shown). It is not known whether the induction of NF-B represents a transient response or is longlasting and contributes to the hepatocarcinogenic effects of long term and high dose administration of peroxisome proliferators to rodents (52) . Spleens of animals provided therapeutic doses of DHEAS or WY-14,643 that have previously been demonstrated by us to cause marked reductions in splenic NF-B activity, inflammatory cytokine production, and tissue TBARS levels (34) , (approximately 40-fold lower than peroxisome proliferating doses) showed no nuclear NF-B-inducing activity (Fig. 2) . Consistent with their reported inability to respond to PPAR␣ activators (41) , no nuclear NF-B was observed in young PPAR␣ Ϫ/Ϫ mice treated with DHEAS or WY-14,643 at either the high (peroxisome-proliferating) or low doses (Fig. 2 ). These results demonstrate that, while peroxisome-proliferating doses of PPAR␣-specific activators are capable of activating NF-B, lower doses of PPAR␣ activators appear not to cause deleterious changes in cellular redox balance.
Effects Derived from the Therapeutic Administration of DHEAS or WY-14,643 to Aged Mice Are Dependent upon a Functional PPAR␣-When animals were evaluated at 15 months of age, both PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice were found to abnormally express significant levels of nuclear NF-B in their unstimulated spleens (Fig. 3A) . This observation is consistent with our recent findings in C57BL/6 strain mice (45) . When 15-month-old PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice were treated with therapeutic doses (34) of DHEAS or WY-14,643 (300 -500 and 250 g/day, respectively), or with a supplemental dose of the antioxidant vitamin E (3 IU/day), the PPAR␣ ϩ/ϩ mice exhibited markedly reduced nuclear NF-B activity in their spleens following all three treatments (Fig.  3A) . The levels of nuclear NF-B activity in the treated aged PPAR␣ ϩ/ϩ mice were comparable to the levels seen in the young PPAR␣ ϩ/ϩ mice fed the same diet as aged control animals (identical composition without the supplements). Analysis of whole cell extracts of splenocytes from aged and supplemented-aged mice by Western blotting has revealed similar expression of the NF-B subunit p65 (data not shown). PPAR␣ Ϫ/Ϫ mice responded to treatment with vitamin E by exhibiting a lowering of nuclear NF-B levels (Fig. 3A) and a reduction in constitutive IL-6 (Fig. 3B) and IL-12 production (Fig. 3C) . The treatment of 15-month-old PPAR␣ Ϫ/Ϫ mice with DHEAS or WY-14,643, however, had no modifying influence on splenic NF-B activity (Fig. 3A) or pro-inflammatory cytokine production (Fig. 3, B and C) . Reductions in splenic NF-B activity and cytokine production in PPAR␣ ϩ/ϩ mice, but not in PPAR␣ Ϫ/Ϫ mice, were observed following the systemic treatment of aged animals with DHEAS or WY-14,643 for only 3 days, while both PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice responded rapidly to supplementation with additional vitamin E (data not shown). These results strongly suggest that a functional PPAR␣ is required to promote the beneficial effects of DHEAS or WY-14,643 treatment of aged mice. As expected, the capacity of antioxidant supplementation of aged mice with vitamin E to correct the age-associated dysregulation in the NF-B system is independent of PPAR␣ influences, as this treatment was effective in both the PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice.
Supershift assays of nuclear extracts obtained from aged PPAR␣ ϩ/ϩ mice revealed the presence of both p50 and p65 subunits, with an apparent absence of cRel (Fig. 4) . The presence of two supershifted bands upon the addition of the ␣-p50 antibody indicates the presence of both p50/p50 homodimers and, because of its similar gel mobility to that observed upon the addition of ␣-p65, p50/p65 heterodimers. This conclusion is similar to the observations made by Supakar et al. (53) in their studies of age-associated elevations in liver NF-B activity and is supported by the finding that the addition of both ␣-p50 and ␣-p65 antibodies resulted in the clear appearance of two supershifted bands. Similar results were seen in splenic nuclear extracts obtained from 15-month-old PPAR␣ Ϫ/Ϫ mice (data not shown). These findings, in addition to the observed elevations in IL-6 and IL-12 production, imply that the NF-B found in the nuclear extracts of splenocytes from aged mice is indeed capable of transcription-regulating activities.
The Therapeutic Administration of DHEAS or WY-14,643 Requires a Functional PPAR␣ to Lower the Levels of NF-B Activity and Inflammatory Cytokine Production in Redox-imbalanced Adult
Mice-Dietary supplementation with antioxidants, in particular vitamin E, has been well documented to have beneficial effects on numerous physiologic parameters both during aging and in a number of pro-oxidant disease states (54 -57) . In our hands, dietary supplementation of aged mice with vitamin E was capable of eliciting its antioxidant effects independent of a functional PPAR␣. We therefore questioned whether a depletion of vitamin E from the diets of 2-month-old PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice might rapidly promote a physiologically aged phenotype in a chronologically young animal. Mice were fed a control diet or a diet deficient in vitamin E for a period of 4 weeks. These diets were identical, except that a tocopherol-stripped fat source and vitamin mix containing no added ␣-tocopherol were substituted for the normal fat and vitamin mix, respectively. As expected, the PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice fed control diets showed no measurable nuclear NF-B activity in their spleens. Both the 3-month-old PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ animals consuming the vitamin E-deficient diet, however, exhibited nuclear translocation of NF-B in their spleens (Fig. 5) . Supershift assay of splenic nuclear extracts obtained from these mice showed the presence of NF-B composed of p50 and p65 subunits, similar to what was found in the aged mice (data not shown).
Groups of 2-month-old PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice were maintained on vitamin E-deficient diets for a period of 6 weeks. For the last 2 weeks, subgroups of animals from both diet groups were provided with DHEAS, WY-14,643, or vitamin E supplements. Both PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ vitamin E-depleted mice demonstrated reduced levels of nuclear NF-B activity in their spleens following vitamin E supplementation (Fig. 6A) . Similarly, PPAR␣ ϩ/ϩ mice provided with DHEAS or WY-14,643 demonstrated levels of nuclear NF-B activity that closely resembled the levels found in splenocytes from 2-monthold mice fed the control diet (Fig. 6A) . The PPAR␣ Ϫ/Ϫ mice, however, did not show any reduction in splenic nuclear NF-B levels following dietary supplementation with either DHEAS or WY-14,643 (Fig. 6A) .
The transcription-regulating activity of the NF-B localized to the nucleus in spleens of mice provided with vitamin E-deficient diets was confirmed by ELISA to measure the abnormal constitutive production of the cytokines IL-6 and IL-12. Splenocytes from young PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice cultured overnight without additional stimulation produced only very low levels of IL-6 (Fig. 6B) and IL-12 (Fig. 6C) . However, splenocytes from age-matched PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice maintained on the vitamin E-deficient diet for 6 weeks, which induced the activation of NF-B, demonstrated the spontaneous production of IL-6 and IL-12. This constitutive proinflammatory cytokine production could be effectively reduced in PPAR␣ ϩ/ϩ mice and partially lowered in the PPAR␣ Ϫ/Ϫ animals following the reintroduction of a supplemental dose of vitamin E into the diets for a period of 2 weeks. A supplementation with DHEAS or WY-14,643 to the vitamin E-deficient diets resulted in a reduction of the spontaneous IL-6 and IL-12 production only in the PPAR␣ ϩ/ϩ mice. DHEAS or WY-14,643 administration was completely incapable of lowering the spontaneous production of IL-6 and IL-12 in PPAR␣ Ϫ/Ϫ mice. These results further implicate that the activation of PPAR␣ is capable of having an anti-oxidant effect in mice rendered redox imbalanced either through dietary manipulation or as a normal result of aging.
Activation of PPAR␣ Modulates Tissue Levels of Lipid Peroxides-We and others have previously observed elevated levels of lipid peroxides in the tissues of aged experimental animals and humans (29, (32) (33) (34) 58) . Vitamin E supplementation has been demonstrated to reduce tissue levels of lipid peroxides (34, 59) . In addition, our laboratory has demonstrated that administration of vitamin E or specific activators of PPAR␣ is capable of reducing the age-associated elevations in tissue lipid peroxide levels in the spleen and liver (34). We therefore determined the levels of lipid peroxidation in livers from PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice of various ages. Furthermore, we questioned whether the capacity of DHEAS and WY-14,643 to modulate the amount of cellular lipid peroxides is through the activation of PPAR␣. The TBARS assay was used to measure tissue lipid peroxide levels in liver homogenates from PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice that were young (3 months old), middle aged (12 months old), aged (24 months old), or aged but provided supplementation with DHEAS, WY-14,643, or vitamin E. The lipid peroxide levels in liver homogenates were measured either directly (Fig. 7A) or following in vitro oxidation in the presence of iron (Fig. 7B) . At 3 months of age, both PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice exhibited similarly low levels of tissue lipid peroxidation. By 12 months of age, however, the PPAR␣ Ϫ/Ϫ mice exhibited approximately 2.5-fold elevations in liver TBARS levels than their age-matched PPAR␣ ϩ/ϩ counterparts. At 24 months of age, both strains of mice exhibited elevated TBARS levels both under basal conditions or subsequent to in vitro oxidation. Supplementation of aged PPAR␣ ϩ/ϩ mice with DHEAS or WY-14,643 was capable of reducing tissue lipid peroxides to levels seen in young animals, while similar treatment of aged PPAR␣ Ϫ/Ϫ mice was completely ineffective. As expected, supplementation with the dietary antioxidant vitamin E was capable of reducing the levels of tissue TBARS in both PPAR␣ ϩ/ϩ and PPAR␣ Ϫ/Ϫ mice, although this treatment appeared to be somewhat more effective in PPAR␣ ϩ/ϩ animals. These results suggest that the tissue lipids of PPAR␣ Ϫ/Ϫ mice exhibit indications of oxidative damage and are more susceptible to oxidative stress at an earlier age than PPAR␣ ϩ/ϩ mice. Supplementation with specific activators of PPAR␣ was only capable of lowering the levels of liver lipid peroxides in aged PPAR␣ ϩ/ϩ mice. In addition, liver tissue from aged PPAR␣ ϩ/ϩ animals supplemented with DHEAS or WY-14,643 exhibited greater resistance to lipid peroxidation following an in vitro oxidative stress, suggesting that tissues from these animals have regained an inherent capacity to more effectively cope with naturally encountered oxidative stresses than age-matched PPAR␣ Ϫ/Ϫ mice.
Age-associated Reductions in Splenic Expression of PPAR␣, Acyl-CoA Oxidase, and Catalase Are Reversed following FIG. 6 . The levels of nuclear NF-B and inflammatory cytokine production induced by the feeding of a vitamin E-deficient diet are lowered by dietary supplementation with DHEAS or WY-14,643 in PPAR␣ ؉/؉ mice, but not in PPAR␣ ؊/؊ mice. Beginning at 8 weeks of age, mice were maintained on the normal diet or were fed the vitamin E-deficient diet for a total of 6 weeks. During the final 2 weeks, groups of 3 mice were provided with supplemental vitamin E, WY-14,643, or DHEAS in their diets. Splenocytes were harvested, nuclear extracts were then prepared, and an NF-B EMSA was performed (A). Data shown are typical of mice from each group. Alternatively, splenocytes were cultured in serum-free medium for 24 h and ELISAs were performed on culture supernatants to quantitate IL-6 (B) and IL-12 (C) levels (mean Ϯ S.D. of 3 mice/group). DHEAS Supplementation-Examination of mRNA obtained from the spleens of young, aged, and DHEAS-treated aged C57BL/6 strain mice revealed an age-associated decline in the levels of mRNA encoding PPAR␣, which was accompanied by a similar decrease in mRNA for the peroxisome-associated enzymes acyl-CoA oxidase and catalase (Fig. 8A) . The levels of PPAR␣ mRNA in splenocytes from young mice was determined by densitometric analysis to be between 2.5-and 10-fold higher than in splenocytes from aged animals (data not shown). Therapeutic treatment of aged C57BL/6 mice with DHEAS for 2 weeks, which we have previously demonstrated to reduce the spontaneous activation of NF-B and NF-B-driven genes in the spleen (34) resulted in the up-regulation of PPAR␣, acylCoA oxidase, and catalase mRNA to levels normally observed in young mice (Fig. 8A) . Furthermore, aged C57BL/6 mice supplemented for 2 weeks with vitamin E also demonstrated elevated expression of mRNA for PPAR␣ (Fig. 8B) , suggesting that balancing the cellular redox state may provide a level of transcriptional regulation for this gene. The prooxidant state observed in the cells of aged animals may therefore be a cause of the age-associated reductions in PPAR␣ gene expression. Reciprocally, reductions in PPAR␣ gene expression may, in part, contribute to the prooxidant phenotype of aging through an age-associated deficiency in the efficient modulation of cellular redox state.
DISCUSSION
Elevated levels of cellular oxidative stress contribute to the pathophysiology of a number of clinical conditions, disease states, and to aging. In addition to causing damage to cellular constituents, recent evidence suggests that reactive oxygen species can alter cellular function through their ability to affect signal transduction processes (60) . Our laboratory has recently demonstrated that aged C57BL/6 strain mice express a markedly elevated activity of the redox-regulated transcription factor NF-B in a number of lymphoid organs when compared with young adult controls (34) . Activities by dysregulated cytokines and proteins under NF-B control could be responsible for changes in immune competence and may contribute to other diseases that accompany aging (61) (62) (63) (64) (65) (66) . Supplementing the diets of aged mice with modest doses of chemical agents capable of activating PPAR␣ reduced the nuclear activity of NF-B to levels seen in young animals. This was paralleled by a correction of the dysregulated constitutive expression of a number of NF-B-regulated cytokines and other proteins (see Ref. 34 , and references therein). The experiments described herein were designed to question whether the in vivo NF-B-correcting effects resulting from treatment of aged and redox-imbalanced mice with PPAR␣ activators is mediated through mechanisms that require a functional PPAR␣.
Activation of PPAR␣ in vivo causes an up-regulation of the mRNA and protein levels of a number of peroxisome-and non-peroxisome-associated enzymes, and structural proteins. Included among these induced genes are enzymes responsible for fatty acid ␤-and -oxidation, bile acid and glycerolipid synthesis, amino acid metabolism, certain apolipoproteins and fatty acid-binding proteins, lipoprotein lipase, the antioxidant enzymes catalase and Cu,Zn-superoxide dismutase, and mediators of the glutathione pathway (17, 22) . While the ␤-oxidative enzymes induced by PPAR␣ activators are themselves capable of generating hydrogen peroxide, induction of the antioxidant enzyme catalase appears to be able to effectively counterbalance this effect (67, 68) . Following administration of agents capable of activating PPAR␣, the catalase activity within the cytosol of liver and kidney cells was found to increase greater than 5-fold (69) . Indices of cellular oxidative stress are not demonstrated to be altered following the administration of modest doses of PPAR␣ activators, indicative of the enzymatic antioxidant capacity of the induced catalase (70) .
Activators of PPARs have now been implicated in the protection against pro-oxidant-mediated damage induced by a number of systems. These include protection against transition metal-induced oxidation of LDL-associated lipids, CCl 4 -mediated hepatotoxicity, and others (71) (72) (73) (74) (75) (76) . Recent evidence also suggests that PPAR␣ is capable of regulating plasma levels of lipid peroxides (77) , indices of oxygen radical-mediated damage, and that administration of the PPAR␣ activator bezafibrate reduces circulating lipid peroxide levels (78) . PPAR␣ activation appears to be capable of modulating the duration of an inflammatory response, probably through the transcriptional up-regulation of enzymes necessary for the metabolic clearance of leukotrienes as PPAR␣ Ϫ/Ϫ mice were found to elicit an extended response to inflammatory stimuli (17) .
The cellular activation of PPAR␥ has been demonstrated to antagonize activities by a number of transcription factors, including NF-B, AP-1, and STATs (24, 25) . These effects were possibly achieved through a sequestration of essential transcription coactivators such as p300, Src-1, or CBP, or via direct protein-protein or protein-DNA interactions involving PPAR␥ itself. PPAR␣ also forms stable interactions with other transcription factor complexes, thereby exerting an inhibitory influence on cellular signaling processes (13, 26, 27) . Recently, it was demonstrated, in human aortic smooth muscle cells cultured in vitro, that specific activators of PPAR␣ are capable of inhibiting IL-1-induced IL-6 and prostaglandin production. PPAR␣ activation was also able to inhibit cyclooxygenase-2 expression, primarily through the repression of NF-B transactivation (28) . For any single or combination of the aforementioned reasons, providing aged animals with specific activators of PPAR␣ results in reductions in NF-B activity and, subsequently, causes declines in the expression of NF-B-regulated genes.
The observed age-associated declines in PPAR␣ expression may occur for a number of reasons. The gene encoding PPAR␣ is under the transcriptional control of glucocorticoids (GCS) (79) . As such, PPAR␣ levels fluctuate in rhythm with circulat- ing GCS concentrations and the levels of PPAR␣ are also upregulated during times of stress, which are accompanied by increased GCS secretion by the adrenal glands (80) . Interestingly, the ability to respond to PPAR␣ activators is enhanced in starved mice, a condition that increases circulating GCS concentrations and that has been employed, in the form of caloric restriction, as a therapeutic intervention to prevent a number of pathologic outcomes in aging (81, 82) . However, age-associated declines in tissue responsiveness to the anti-inflammatory effects of GCS have been demonstrated in aged experimental animals despite elevated levels of GCS in the circulation (83) (84) (85) .
Seven putative binding sites for the basal transcription factor Sp1 have been identified in the promoter region of the PPAR␣ gene (86) . The DNA binding activity, and therefore transcription regulating capacity, of a number of transcription factors including Sp1 and the glucocorticoid receptor are susceptible to alterations in cell redox state (87) . Sp1 has been demonstrated to possess reduced DNA binding efficiency in nuclear extracts obtained from the tissues of aged rats (87, 88) . An increase in the intracellular oxidative state in aged animals and the lowering of oxidative state following administration of PPAR␣ activators or ␣-tocopherol suggest that the ability of Sp1 or glucocorticoid receptor to act as a transcriptional regulators may be affected in our model.
The NF-B-driven cytokines tumor necrosis factor-␣, IL-1␤, and IL-6 have been demonstrated to cause a reduction in the expression of PPAR␣ (89, 90) . These same cytokines have been found to be expressed at higher levels by cells from aged animals and, in the case of IL-6, can be demonstrated in the serum of aged humans and mice (61, 62, 66) . Whether the effects of these cytokines are mediated through the generation of intracellular ROS, or through another defined cell-signaling mechanism, is currently being studied in our laboratory. Whatever the reason(s) behind the reductions in PPAR␣ expression, our data offer a possible explanation for observations that it is more difficult to induce responses following administration of PPAR␣ activators to aged rodents (91) .
A number of the consequences of the age-associated decline in PPAR␣ expression may contribute to the molecular alterations observed in aging. The decreased expression of acyl-CoA oxidase may contribute to the age-associated accumulation of lipid stores and an inability to efficiently metabolize very long chain and polyunsaturated fatty acids, outcomes evidenced by increases in membrane rigidity and oxidative damage to lipids (91) (92) (93) . It has been demonstrated, employing the acyl-CoA knockout mouse (94) , that elevated levels of hydrogen peroxide are present in liver tissue at 4 months of age (95). This is followed by a lowering of liver H 2 O 2 levels as the animals age, during which time they undergo liver regeneration as a result of spontaneous PPAR␣ activation from endogenous agonists (95) . Our results demonstrate that oxidative damage to tissue lipids is reduced following the administration of PPAR␣-specific activators. The age-associated decrease in catalase mRNA expression may have an enormous impact on the overall cellular oxidative state because of its capacity to detoxify hydrogen peroxide, the reactive oxygen species which itself has been demonstrated to be sufficient for the activation of NF-B (51, 60, 96 -98) . The ability of dietary supplementation with PPAR␣ activators to facilitate the transcriptional up-regulation of acylCoA oxidase and catalase may, in turn, increase the turnover of damaged and chain-propagating lipids and other pro-inflammatory fatty acid derivatives, as well as lowering cellular levels of hydrogen peroxide and other ROS. This would, in turn, cause reductions in the level of NF-B activity as well as lower the production of NF-B-driven gene products.
It remains to be established whether the administration of PPAR␣-specific activators to mice with an intact PPAR␣ gene elicits its beneficial effects directly within the spleen or in another organ(s) with higher levels of PPAR␣ expression, such as in the liver (3, 5) . Either of these primary sites of PPAR␣-ligand interaction could allow for the re-establishment of an appropriate redox balance in certain individual cells within a particular organ and possibly in the whole animal. The cells which are beneficially affected by PPAR␣ activators are likely to be those expressing PPAR␣, as well as those cells in the immediate vicinity of PPAR␣-expressing cells. Recent work by our laboratory and others has provided convincing evidence that consideration of the roles of PPAR␣, its activators, and PPAR␣-regulated genes may have important clinical applications toward maintaining redox balance during aging and reestablishing redox balance caused by pro-inflammatory or oxidant stress-related disease states. If similar age-associated changes are observed in humans, it might offer an explanation for the increased incidence of a number of disease states with aging.
